
即时询价 ×
* 必填项
请填妥以下表格,您将在一分钟内得到邮件机器人给你的报价。
Inquiry Online
×
* Required Fields.
Please complete the form below and we will contact you shortly.
Bulk Inquiry
×
* Required Fields.
Please complete the form below and we will contact you shortly.

CAS号 | 1844849-10-0 | 货号 | BCP45826 |
中文名 | PF-06821497 | ||
英文名 | PF-06821497 | ||
中文别名 | |||
英文别名 | PF06821497;PF 06821497; | ||
SMILES | CC1=CC(=C(C(=O)N1)CN2CCC3=C(C=C(C(=C3C2=O)Cl)C(C4COC4)OC)Cl)OC | ||
化学名称 | |||
分子式 | C22H24Cl2N2O5 | 分子量 | 467.34 |
纯度 | 98% | 配送 | 惯例下常温包邮 |
产品描述 | EZH2 Inhibitor PF-06821497 is an orally available selective inhibitor of the histone lysine methyltransferase (HMT) enhancer of zeste homolog 2 (EZH2), with potential antineoplastic activity. Upon oral administration, EZH2 inhibitor PF-06821497 selectively targets, binds to and inhibits the activity of EZH2. Inhibition of EZH2 specifically prevents the methylation of histone H3 on lysine 27 (H3K27). This decrease in histone methylation alters gene expression patterns associated with cancer pathways and results in decreased proliferation of EZH2-expressing cancer cells. EZH2, an HMT class enzyme and the catalytic subunit of the polycomb repressive complex 2 (PRC2), is overexpressed or mutated in a variety of cancer cells and plays a key role in tumor cell proliferation; its expression is correlated with tumor initiation, progression, stem cell self-renewal, migration and angiogenesis. |
相关产品推荐
查看更多 >Tags:PF-06821497 供应商,PF-06821497 购买,PF-06821497 生产,PF-06821497 批量,PF-06821497 供应,PF-06821497 订购,PF-06821497 采购